Hiroko Nishida

1.8k total citations
65 papers, 1.3k citations indexed

About

Hiroko Nishida is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Hiroko Nishida has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Biochemistry and 15 papers in Oncology. Recurrent topics in Hiroko Nishida's work include Eicosanoids and Hypertension Pharmacology (15 papers), Inflammatory mediators and NSAID effects (13 papers) and Peptidase Inhibition and Analysis (8 papers). Hiroko Nishida is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (15 papers), Inflammatory mediators and NSAID effects (13 papers) and Peptidase Inhibition and Analysis (8 papers). Hiroko Nishida collaborates with scholars based in Japan, United States and Switzerland. Hiroko Nishida's co-authors include Hiroshi Fujimoto, Katsumi Ajisaka, Mitchell R. Hammer, Richard L. Wiseman, Satoru Sakuma, Chikao Morimoto, Yohko Fujimoto, Taketo Yamada, Tadashi Fujita and Hiroto Yamazaki and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Hiroko Nishida

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Nishida Japan 20 495 202 191 144 134 65 1.3k
Richard J. Alexander United States 17 211 0.4× 98 0.5× 28 0.1× 28 0.2× 25 0.2× 49 886
Maria Andersson Sweden 21 421 0.9× 73 0.4× 77 0.4× 58 0.4× 14 0.1× 43 1.2k
David W. Wilson United States 16 236 0.5× 51 0.3× 58 0.3× 73 0.5× 71 0.5× 57 1.1k
R.J. Hodgkiss United Kingdom 19 347 0.7× 107 0.5× 23 0.1× 108 0.8× 47 0.4× 41 1.1k
Charles R. Cooper United States 12 839 1.7× 177 0.9× 32 0.2× 32 0.2× 30 0.2× 41 2.0k
Steven R. Harris United States 16 324 0.7× 245 1.2× 35 0.2× 9 0.1× 28 0.2× 27 1.1k
Marjorie Perloff United States 21 1.2k 2.4× 464 2.3× 13 0.1× 28 0.2× 90 0.7× 112 3.1k
Ming Ji China 26 1.1k 2.2× 322 1.6× 15 0.1× 35 0.2× 63 0.5× 92 2.3k
Louis Rosenfeld United States 26 611 1.2× 112 0.6× 29 0.2× 50 0.3× 128 1.0× 106 2.1k
Yuka Fujimoto Australia 25 779 1.6× 28 0.1× 116 0.6× 14 0.1× 38 0.3× 96 2.2k

Countries citing papers authored by Hiroko Nishida

Since Specialization
Citations

This map shows the geographic impact of Hiroko Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Nishida more than expected).

Fields of papers citing papers by Hiroko Nishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Nishida. The network helps show where Hiroko Nishida may publish in the future.

Co-authorship network of co-authors of Hiroko Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Nishida. A scholar is included among the top collaborators of Hiroko Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Nishida. Hiroko Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishida, Hiroko, Hiroshi Suzuki, Masao Hori, & Katsuyuki Obara. (2018). Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission. Leukemia Research Reports. 10. 11–15. 5 indexed citations
2.
Nishida, Hiroko. (2018). Bone-targeted agents in multiple myeloma. Hematology Reports. 10(1). 7401–7401. 10 indexed citations
3.
Nishida, Hiroko, et al.. (2018). CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma. Blood Cancer Journal. 8(11). 99–99. 18 indexed citations
4.
Nishida, Hiroko, et al.. (2014). Optic nerve involvement of Waldenström’s macroglobulinemia: with autopsy findings. Neurological Sciences. 35(8). 1299–1302. 2 indexed citations
5.
Yamada, Kohji, Hiroko Nishida, Wenlin Du, et al.. (2013). Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription. PLoS ONE. 8(4). e62304–e62304. 31 indexed citations
6.
Nishida, Hiroko, Masao Hori, & Katsuyuki Obara. (2011). Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings. Neurological Sciences. 33(2). 403–407. 13 indexed citations
7.
Yamazaki, Hiroto, Hiroko Nishida, Toshihiro Okamoto, et al.. (2011). Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. Biochemical and Biophysical Research Communications. 409(1). 14–21. 40 indexed citations
8.
Yamazaki, Hiroto, Hiroko Nishida, Satoshi Iwata, Nam H. Dang, & Chikao Morimoto. (2009). CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. Biochemical and Biophysical Research Communications. 383(2). 172–177. 37 indexed citations
9.
Yamazaki, Hiroto, et al.. (2007). Stem cell properties and the side population cells as a target for interferon-α in adult T-cell leukemia/lymphoma. Biochemical and Biophysical Research Communications. 364(4). 808–814. 18 indexed citations
10.
Nishida, Hiroko, et al.. (2006). MR findings of granulocytic sarcoma of the breasts. British Journal of Radiology. 79(945). e112–e115. 7 indexed citations
11.
Nishida, Hiroko. (1999). Bond Mechanism between continuous fiber and concrete. 21(3). 1507–1512. 6 indexed citations
12.
13.
Sakuma, Satoru, et al.. (1997). Peroxynitrite Induces the Conversion of Xanthine Dehydrogenase to Oxidase in Rabbit Liver. Biochemical and Biophysical Research Communications. 230(2). 476–479. 46 indexed citations
14.
Miura, Hiroaki, et al.. (1996). Effect of Crude Fractions ofPsoralea corylifoliaSeed Extract on Bone Calcification. Planta Medica. 62(2). 150–153. 39 indexed citations
15.
Nishida, Hiroko, et al.. (1996). 15-hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1300(3). 171–176. 17 indexed citations
16.
Fujita, Tadashi, et al.. (1995). Effects of fatty acids and fatty acyl CoA esters on Cu2+-induced conversion of xanthine dehydrogenase to oxidase in rabbit liver. Free Radical Biology and Medicine. 19(4). 487–491. 5 indexed citations
17.
Sakuma, Satoru, Yukari Fujimoto, Kenji Doi, et al.. (1994). Existence of an Enzymatic Pathway Furnishing Arachidonic Acid for Prostaglandin Synthesis from Arachidonoyl CoA in Rabbit Kidney Medulla. Biochemical and Biophysical Research Communications. 202(2). 1054–1059. 7 indexed citations
18.
Sakuma, Satoru, et al.. (1993). Effect of 13-hydroperoxyoctadecadienoic acid on 15-hydroxy prostaglandin dehydrogenase activity in rabbit kidney cortex. Prostaglandins. 46(2). 157–165. 2 indexed citations
19.
Fujimoto, Yohko, Tohru Nakajima, Yutaka Murakami, et al.. (1992). Effects of fatty acyl-coenzyme A esters on prostaglandin synthesis in rabbit kidney medulla microsomes. Prostaglandins Leukotrienes and Essential Fatty Acids. 47(4). 265–268. 13 indexed citations
20.
Fujimoto, Yohko, Shinji Takai, Kuniharu Matsuno, et al.. (1992). Effect of tert-butyl hydroperoxide on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in rabbit platelets. Prostaglandins Leukotrienes and Essential Fatty Acids. 47(4). 259–264. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Alexander Breakdown of academic impact, for papers by Maria Andersson Breakdown of academic impact, for papers by David W. Wilson Breakdown of academic impact, for papers by R.J. Hodgkiss Breakdown of academic impact, for papers by Charles R. Cooper Breakdown of academic impact, for papers by Steven R. Harris Breakdown of academic impact, for papers by Marjorie Perloff Breakdown of academic impact, for papers by Ming Ji Breakdown of academic impact, for papers by Louis Rosenfeld Breakdown of academic impact, for papers by Yuka Fujimoto
Rankless by CCL
2026